Nilza Karina Cabral Gonçalves

Biography

To support the Clinical Research Centre of the Lisbon Medical Academic Centre (CIC‐CAML) in all aspects related with drug development studies. The decision to create the CIC‐CAML as a facility unit for clinical and translational research was done recently and the infrastructures for the centre are now being implemented. CIC‐CAML will favor the design and conduct of early phase clinical trials and proof of concept studies. The CIC‐CAML has unique clinical and translational capacities to become a top‐level European clinical research centre with innovative investigator‐initiated projects, active collaborations with international networks and partnerships with industry with a scope extending throughout the translational continuum. At the current stage, compounds being developed or studied at the IMM Units have reached a clinical stage and the first trials in patients are being designed and will start later this year. Some of the first exploratory trials will be conducted in the CHLN with the support of the CIC CAML.  

Research Interest

 CLINICAL SCIENCE